FOOT-AND-MOUTH DISEASE VIRUS (FMDV) CHARACTERIZATION AT THE FEDERAL CENTER FOR ANIMAL HEALTH (ARRIAH), VLADIMIR, RUSSIA
Project Number: 0210-22310-004-16
Start Date: Sep 01, 2009
End Date: Sep 30, 2013
To facilitate the characterization of contemporary FMDV strains collected from the Middle Eastern region by ARRIAH in ARRIAH laboratories. All successfully characterized FMDV strains will be shipped to DHS and ARS, PIADC for use in the ARS research and DHS FMD countermeasure programs. This amendment expands the original milestones and deliverables to include scientific consulting services for the Russian research project.
The All-Russian Research Institute of Animal Health (ARRIAH) in Vladimir, Russia is the lead veterinary research facility in Russia and the designated location for FMD monitoring, research, and vaccine development. Additionally, it is an OIE Collaborating Center for FMD. ARRIAH has a collection of approximately 550 field isolates of FMD strains, many of which are from critical regions of interest, such as the Middle East. Research on these isolates is critical for world health, and could yield not only several new sub serotypes, but also new primary serotypes, beyond the known seven. The results of such research would be extremely important for the world community’s ability to quickly identify, track, and mitigate FMD outbreaks, as well as for the development of new FMD vaccines for national veterinary stockpiles and commercial sale.
DHS funding will complement State Department funding of the ARS – Russia proposal entitled “Analysis of the evolution of Foot-and-Mouth Disease Virus (FMDV) genome recovered from persistently infected cattle,” ARS #573. Elizabeth Rieder, ARS – PIADC, is the ARS collaborator on this project. Specifically, DHS funds will support Task 3 “FMDV field surveillance (characterization of newly emerged FMDV field isolates). AARIAH will characterize contemporary FMDV strains collected from the Middle Eastern region. The characterization will be conducted by ARRIAH in ARRIAH laboratories and results summarized in a sumbitted report to ARS and DHS. All successfully characterized FMDV strains will be shipped to ARS and DHS, PIADC for use in ARS research and DHS FMD countermeasure programs. DHS will reimburse ARRIAH for these services, including scientific and scientific support salaries, miscellaneous supplies and equipment, animal purchases and per diems.